1. Home
  2. CURX vs DTSS Comparison

CURX vs DTSS Comparison

Compare CURX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CURX

Curanex Pharmaceuticals Inc

HOLD

Current Price

$0.27

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.75

Market Cap

9.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURX
DTSS
Founded
2018
2014
Country
United States
China
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
9.0M
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
CURX
DTSS
Price
$0.27
$0.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
61.7K
286.8K
Earning Date
09-09-2025
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.42
EPS
N/A
N/A
Revenue
N/A
$71,616,820.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
198.70
52 Week Low
$0.26
$0.58
52 Week High
$9.18
$2.50

Technical Indicators

Market Signals
Indicator
CURX
DTSS
Relative Strength Index (RSI) 38.14 45.19
Support Level $0.26 $0.61
Resistance Level $0.40 $1.00
Average True Range (ATR) 0.03 0.14
MACD -0.00 -0.01
Stochastic Oscillator 13.23 33.87

Price Performance

Historical Comparison
CURX
DTSS

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

Share on Social Networks: